Table 2.
Immunological features of patients with AIH and SSc
| Author (Literature Ref) | Liver disease | CDT | ANA | ACA | SMA | LKM | AMA | dsDNA AAb |
|---|---|---|---|---|---|---|---|---|
| Ishikawa et al (6) | AIH | lSSc | + | + | + | ND | - | ND |
| Lis-Swiety et al (8) | AIH | SSc-PM | + | ND | + | - | - | ND |
| Marie et al (9) | AIH | lSSc | + | + | - | - | - | ND |
| Pamfil et al (11) | AIH | SSc-PM | + | + | - | - | - | - |
| Rodrigues et al (12) | AIH | dSSc | ND | ND | - | - | + | ND |
| Ngo Mandag et al (33) | AIH | lSSc | + | + | - | - | - | ND |
| Yabe et al (34) | AIH | lSSc | - | - | NK | NK | - | ND |
CDT: connective tissue disease; ANA: antinuclear antibodies; ACA: anticentromere antibodies; SMA: anti-smooth muscle antibodies; LKM: anti-liver-kidney microsome-1 antibodies; AMA: antimitochondrial antibodies; lSSc: limited SSc; dSSc: diffuse SSc; SSc-PM: systemic sclerosis-polymyositis overlap syndrome; +: positive; -: negative; ND: not determined.